MREO Mereo BioPharma Group plc - American Depositary Shares
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 11, 2026
$0,38
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$0,20mínimo 52 semanas
$2,37máximo 52 semanas
Capitalización Bursátil (MRQ)
$303M
P/E
-7.6
BPA
$-0.05
Ingresos
$500.0K
tus insignias
Rango 52S
$0–$2
Calificación del Analista
STRONG BUY
Precio Objetivo
$2
P/E
-7.6
ROE
-88.1%
Margen de Beneficio Neto
-8375.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
MREO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.38
Capitalización Bursátil (MRQ)
$303M
P/E
-7.6
BPA
$-0.05
Ingresos
$500.0K
ROE
-88.1%
Rango 52S
$0–$2
MREO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$500.0K2022-12-31 → 2025-12-31
BPA$-0.052022-12-31 → 2025-12-31
Flujo de caja libre$-31M2023-12-31 → 2025-12-31
Margen neto-8375.6%2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MREO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -7.6promedio 5A ≈-41.5 | ≈-41.5 | · | · | |
| P/S | 606.2 | · | · | · | |
| P/C (MRQ) | 10.6promedio 5A ≈28.2 | ≈28.2 | · | · | |
| Precio / FCF (TTM) | -12.0 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -12.0promedio 5A ≈-56.7 | ≈-56.7 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 10.7promedio 5A ≈28.7 | ≈28.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MREO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Operating Margin (Margen Operativo) | -8021.4% | · | · | · | |
| EBITDA Margin (Margen EBITDA) | -8021.4% | · | · | · | |
| Pretax Margin (Margen antes de impuestos) | -8375.6% | · | · | · | |
| Net Profit Margin (Margen de Beneficio Neto) | -8375.6% | · | · | · | |
| ROA | -68.5%promedio 5A ≈-56.7% | ≈-56.7% | · | · | |
| ROE | -88.1%promedio 5A ≈201.3% | ≈201.3% | · | · | |
| ROIC | -98.0%promedio 5A ≈-77.0% | ≈-77.0% | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MREO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 5.9promedio 5A ≈7.5 | ≈7.5 | · | · | |
| Quick Ratio (Ratio Rápido) | 9.5promedio 5A ≈6.9 | ≈6.9 | · | · | |
| Interest Coverage (Cobertura de Intereses) | -157.3promedio 5A ≈-67.2 | ≈-67.2 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | MREO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | · | · | |
| Revenue / Employee (Ingresos / Empleado) | ≈$12.8K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-130.7%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-0.01 | $-0.01 | — |
| 31 de marzo de 2026 | May 11, 2026 | $-0.01 | $-0.01 | 2.0% |
| 31 de diciembre de 2025 | $-0.01 | $-0.01 | 23.7% | |
| 30 de septiembre de 2025 | $-0.01 | $-0.02 | 59.7% | |
| 30 de junio de 2025 | $-0.10 | $-0.02 | -498.8% | |
| 31 de marzo de 2025 | $-0.10 | $-0.01 | — | |
| 31 de diciembre de 2024 | $-0.05 | $-0.01 | -240.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $500.0K | $0 | $10M | $0 | |
| R&D Expense | $18M | $21M | $17M | $29M | |
| SG&A Expense | $23M | $26M | $18M | $26M | |
| Operating Income | $-40M | $-47M | $-28M | $-54M | |
| Interest Expense | $255.0K | $1M | $3M | $4M | |
| Interest Income | $104.0K | $0 | $2M | $840.0K | |
| Other Non-op | $300.0K | $0 | $-10.0K | $1M | |
| Pretax Income | $-42M | $-43M | $-30M | $-43M | |
| Income Tax | $0 | $0 | $-532.0K | $-718.0K | |
| Net Income | $-42M | $-43M | $-29M | $-42M | |
| EPS (Basic) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | |
| EPS (Diluted) | $-0.05 | $-0.06 | $-0.04 | $-0.07 | |
| Shares (Basic) | 797,119,632 | 739,624,264 | 659,453,921 | 603,196,403 | |
| Shares (Diluted) | 797,119,632 | 739,624,264 | 659,453,921 | 603,196,403 | |
| EBITDA | $-40M | $-47M | $-28M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $70M | $57M | $68M | |
| Prepaid Expense | $3M | $2M | $5M | $5M | |
| Current Assets | $45M | $75M | $64M | $75M | |
| PP&E (Net) | $137.0K | $257.0K | $405.0K | $551.0K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | |
| Accum. Depreciation | $1M | $949.0K | $800.0K | $736.0K | |
| Intangibles | $516.0K | $643.0K | $1M | $0 | |
| Total Assets | $46M | $76M | $66M | $77M | |
| Accounts Payable | $1M | $2M | $2M | $3M | |
| Accrued Liabilities | $2M | $4M | $5M | $5M | |
| Current Liabilities | $4M | $14M | $9M | $24M | |
| Capital Leases | $0 | $187.0K | $906.0K | $1M | |
| Other Non-current Liabilities | $661.0K | $565.0K | $764.0K | $0 | |
| Total Liabilities | $5M | $15M | $16M | $26M | |
| Common Stock | $3M | $3M | $3M | $2M | |
| Paid-in Capital | $550M | $540M | $486M | $477M | |
| Retained Earnings | $-501M | $-463M | $-420M | $-405M | |
| Treasury Stock | · | $0 | $1M | $1M | |
| AOCI | $-11M | $-19M | $-17M | $-22M | |
| Stockholders' Equity | $41M | $61M | $51M | $51M | |
| Liabilities + Equity | $46M | $76M | $66M | $77M | |
| Shares Outstanding | 795,658,504 | 775,728,034 | 701,217,089 | 624,928,519 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $8M | $7M | $5M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | |
| Amort. of Intangibles | $465.0K | $438.0K | $395.0K | $0 | |
| Operating Cash Flow | $-31M | $-33M | $-21M | $-49M | |
| CapEx | $20.0K | $0 | $0 | $13.0K | |
| Investing Cash Flow | $-20.0K | $-699.0K | $-419.0K | $2M | |
| Stock Issued | $39.0K | $47M | $12M | $0 | |
| Net Stock Activity | $39.0K | $47M | $12M | · | |
| Financing Cash Flow | $327.0K | $46M | $8M | $200.0K | |
| Net Change in Cash | · | $12M | $-11M | · | |
| Taxes Paid | · | $0 | $-1M | $2M | |
| Free Cash Flow | $-31M | · | $-21M | · | |
| Levered FCF | $-31M | · | $-24M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -8021.4% | · | -284.2% | · | |
| Net Margin | -8375.6% | · | -294.7% | · | |
| Pretax Margin | -8375.6% | · | -300.0% | · | |
| EBITDA Margin | -8021.4% | · | -284.2% | · | |
| ROA | -68.5% | -60.5% | -40.9% | · | |
| ROE | -88.1% | 747.9% | -56.0% | · | |
| ROIC | -98.0% | -77.7% | -55.2% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.5 | 5.4 | 6.7 | · | |
| Quick Ratio | 9.5 | 5.0 | 6.1 | · | |
| Interest Coverage | -157.3 | -34.6 | -9.9 | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.05 | $0.08 | $0.07 | · | |
| Revenue / Share | $0.00 | $0.00 | $0.02 | · | |
| Cash Flow / Share | $-0.04 | $-0.04 | $-0.03 | · | |
| Cash / Share | $0.05 | $0.09 | $0.08 | · | |
| EPS (TTM) | $-0.05 | $-0.06 | $-0.04 | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $500.0K | $0 | $10M | · | |
| Net Income TTM | $-42M | $-43M | $-29M | · | |
| Market Cap | $332M | $2.72B | $1.62B | · | |
| P/E | -8.3 | -58.3 | -57.8 | · | |
| P/S | 663.6 | · | 162.0 | · | |
| P/B | 8.1 | 44.5 | 32.1 | · | |
| P / Tangible Book | 8.2 | 45.0 | 32.8 | · | |
| P / Cash Flow | -10.7 | -82.7 | -76.7 | · | |
| P / FCF | -10.7 | · | -76.7 | · | |
| Earnings Yield | -12.0% | -1.7% | -1.7% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | · | $0 | $0 | $500.0K | · | $0 | $0 | $0 | $0 | $1M | $0 | $9M | $0 | |
| R&D Expense | $2M | $5M | $4M | $4M | $5M | $4M | $9M | $3M | $5M | $4M | $5M | $4M | $4M | $5M | |
| SG&A Expense | $5M | $4M | $4M | $6M | $5M | $7M | $6M | $6M | $8M | $6M | $4M | $6M | $3M | $6M | |
| Operating Income | $-7M | $-9M | $-8M | $-10M | $-10M | $-11M | $-15M | $-9M | $-13M | $-10M | $-7M | $-9M | $-811.0K | $-11M | |
| Interest Expense | $16.0K | $20.0K | $23.0K | $28.0K | $24.0K | $180.0K | $376.0K | $353.0K | $331.0K | $310.0K | $352.0K | $700.0K | $1M | $800.0K | |
| Interest Income | $19.0K | $31.0K | $70.0K | $-1M | $589.0K | $0 | $-2M | $983.0K | $559.0K | $617.0K | $763.0K | $689.0K | $373.0K | $306.0K | |
| Other Non-op | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-4.0K | $0 | $0 | $-6.0K | |
| Pretax Income | $-7M | $-7M | $-7M | $-7M | $-15M | $-13M | $-7M | $-15M | $-12M | $-9M | $-10M | $-7M | $-2M | $-12M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-532.0K | $0 | $0 | $0 | |
| Net Income | $-7M | $-7M | $-7M | $-7M | $-15M | $-13M | $-7M | $-15M | $-12M | $-9M | $-9M | $-7M | $-2M | $-12M | |
| EPS (Basic) | $-0.01 | $-0.01 | $0.00 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.02 | |
| EPS (Diluted) | $-0.01 | $-0.01 | $0.00 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.02 | |
| Shares (Basic) | 803,562,708 | 801,805,570 | · | 799,947,013 | 799,435,329 | 784,279,387 | · | 770,146,589 | 770,146,589 | 700,263,490 | · | 684,974,190 | 628,421,064 | 623,925,635 | |
| Shares (Diluted) | 803,562,708 | 801,805,570 | · | 799,947,013 | 799,435,329 | 784,279,387 | · | 770,146,589 | 770,146,589 | 700,263,490 | · | 684,974,190 | 628,421,064 | 623,925,635 | |
| EBITDA | $-7M | $-9M | · | $-10M | $-10M | $-11M | · | $-9M | $-13M | $-10M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $36M | $41M | $49M | $56M | $62M | $70M | $81M | $87M | $49M | $57M | · | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $4M | $4M | $3M | $5M | · | · | · | |
| Current Assets | $33M | $40M | $45M | $52M | $61M | $67M | $75M | $87M | $94M | $53M | $64M | · | · | · | |
| PP&E (Net) | $54.0K | $91.0K | $137.0K | $174.0K | $218.0K | $247.0K | $257.0K | $315.0K | $338.0K | $360.0K | $405.0K | · | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | |
| Accum. Depreciation | $1M | $978.0K | $1M | $1M | $1M | $1M | $949.0K | $964.0K | $877.0K | $836.0K | $800.0K | · | · | · | |
| Intangibles | $256.0K | $381.0K | $516.0K | $643.0K | $470.0K | $554.0K | $643.0K | $799.0K | $866.0K | $972.0K | $1M | · | · | · | |
| Total Assets | $35M | $41M | $46M | $54M | $63M | $68M | $76M | $89M | $96M | $56M | $66M | · | · | · | |
| Accounts Payable | $1M | $3M | $1M | $879.0K | $1M | $3M | $2M | $2M | $3M | $2M | $2M | · | · | · | |
| Accrued Liabilities | $2M | $2M | $2M | $4M | $5M | $3M | $4M | $4M | $4M | $3M | $5M | · | · | · | |
| Current Liabilities | $6M | $6M | $4M | $6M | $8M | $7M | $14M | $14M | $15M | $11M | $9M | · | · | · | |
| Capital Leases | $0 | · | $0 | $0 | $0 | $0 | $187.0K | $394.0K | $552.0K | $727.0K | $906.0K | · | · | · | |
| Other Non-current Liabilities | $370.0K | $362.0K | $661.0K | $652.0K | $352.0K | $325.0K | $565.0K | $568.0K | $536.0K | $513.0K | $764.0K | · | · | · | |
| Total Liabilities | $6M | $7M | $5M | $7M | $8M | $8M | $15M | $16M | $17M | $13M | $16M | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | · | · | |
| Paid-in Capital | $552M | $551M | $550M | $548M | $546M | $544M | $540M | $536M | $535M | $487M | $486M | · | · | · | |
| Retained Earnings | $-515M | $-508M | $-501M | $-494M | $-487M | $-472M | $-463M | $-456M | $-441M | $-429M | $-420M | · | · | · | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $0 | $0 | $1M | · | · | · | |
| AOCI | $-12M | $-13M | $-11M | $-11M | $-9M | $-15M | $-19M | $-11M | $-18M | $-18M | $-17M | · | · | · | |
| Stockholders' Equity | $29M | $34M | $41M | $47M | $54M | $60M | $61M | $73M | $79M | $43M | $51M | · | · | · | |
| Liabilities + Equity | $35M | $41M | $46M | $54M | $63M | $68M | $76M | $89M | $96M | $56M | $66M | · | · | · | |
| Shares Outstanding | 798,093,044 | 798,078,829 | 795,658,504 | 795,484,404 | 795,001,444 | 795,001,444 | 775,728,034 | 773,672,299 | 768,821,274 | 701,349,434 | 701,217,089 | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $815.0K | $2M | $941.0K | $2M | |
| Amort. of Intangibles | $127.0K | $127.0K | $424.0K | $-183.0K | $118.0K | $106.0K | $110.0K | $112.0K | $108.0K | $108.0K | $115.0K | $109.0K | $107.0K | $64.0K | |
| Operating Cash Flow | $-6M | $-4M | $-8M | $-7M | $-8M | $-8M | $-9M | $-8M | $-8M | $-8M | $-7M | $3M | $-8M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $20.0K | $0 | $0 | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $0 | $-300.0K | $0 | $300.0K | $0 | $-320.0K | $0 | $0 | $1.0K | $-700.0K | $0 | $0 | $0 | $-419.0K | |
| Stock Issued | · | · | $39.0K | $0 | · | · | $0 | $0 | · | · | $0 | $12M | · | · | |
| Financing Cash Flow | $0 | $0 | $39.0K | $0 | $-134.0K | $422.0K | $-40.0K | $-594.0K | $47M | $0 | $0 | $8M | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | |
| Taxes Paid | · | · | · | · | · | · | · | · | $0 | $0 | · | · | $0 | $37.0K | |
| Free Cash Flow | · | $-4M | · | · | · | $-8M | · | · | · | · | · | · | · | · | |
| Levered FCF | · | $-4M | · | · | · | $-9M | · | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -2099.8% | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | · | · | · | -2923.2% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | -2923.2% | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -2099.8% | · | · | · | · | · | · | · | · | · | |
| ROA | -14.4% | -12.3% | · | -9.9% | -18.4% | -20.7% | · | -33.8% | -25.5% | -32.0% | · | · | · | · | |
| ROE | -16.9% | -14.3% | · | -11.8% | -22.0% | -25.0% | · | -41.4% | -31.2% | -41.8% | · | · | · | · | |
| ROIC | -24.5% | -25.7% | · | -21.5% | -19.4% | -18.6% | · | -12.9% | -16.3% | -23.1% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | 6.5 | · | 8.7 | 8.1 | 8.9 | · | 6.1 | 6.1 | 4.9 | · | · | · | · | |
| Quick Ratio | 5.3 | 5.9 | · | 8.1 | 7.4 | 8.3 | · | 5.7 | 5.7 | 4.4 | · | · | · | · | |
| Interest Coverage | -439.4 | -438.3 | · | -357.7 | -437.5 | -62.2 | · | -26.6 | -38.7 | -31.9 | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.04 | $0.04 | · | $0.06 | $0.07 | $0.08 | · | $0.09 | $0.10 | $0.06 | · | · | · | · | |
| Revenue / Share | $0.00 | · | · | $0.00 | $0.00 | · | · | $0.00 | $0.00 | $0.00 | · | · | · | · | |
| Cash Flow / Share | · | $-0.01 | · | · | · | $-0.01 | · | · | · | $-0.01 | · | · | · | · | |
| Cash / Share | $0.04 | $0.05 | · | $0.06 | $0.07 | $0.08 | · | $0.10 | $0.11 | $0.07 | · | · | · | · | |
| EPS (TTM) | $-0.03 | $-0.04 | · | $-0.06 | $-0.07 | $-0.07 | · | $-0.06 | $-0.05 | $-0.03 | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | $0 | · | $1M | $1M | $10M | · | · | · | · | |
| Net Income TTM | $-28M | $-36M | · | $-42M | $-50M | $-47M | · | $-45M | $-37M | $-26M | · | · | · | · | |
| Market Cap | $254M | $263M | · | $1.64B | $2.15B | $1.79B | · | $3.18B | $2.77B | $2.31B | · | · | · | · | |
| P/E | -10.6 | -8.2 | · | -34.3 | -38.7 | -32.1 | · | -68.5 | -72.0 | -110.0 | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | 3179.8 | 2767.8 | 231.4 | · | · | · | · | |
| P/B | 8.9 | 7.7 | · | 35.2 | 39.8 | 29.8 | · | 43.8 | 35.2 | 54.0 | · | · | · | · | |
| P / Tangible Book | 8.9 | 7.8 | · | 35.7 | 40.1 | 30.0 | · | 44.3 | 35.6 | 55.3 | · | · | · | · | |
| P / Cash Flow | · | -61.1 | · | · | · | -214.8 | · | · | · | -289.6 | · | · | · | · | |
| Earnings Yield | -9.4% | -12.1% | · | -2.9% | -2.6% | -3.1% | · | -1.5% | -1.4% | -0.91% | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Ingresos | $500.0K | $0 | $10M | $0 |
| Margen Operativo % | -8021.4% | · | -284.2% | · |
| Beneficio neto | $-42M | $-43M | $-29M | $-42M |
| EPS Diluido | $-0.05 | $-0.06 | $-0.04 | $-0.07 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Ratio corriente | 10.5 | 5.4 | 6.7 | · |
| Ratio Rápido | 9.5 | 5.0 | 6.1 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Flujo de caja libre | $-31M | · | $-21M | · |
Propietarios institucionales (13F) 66 declarantes · $18.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
66
Valor en tenencia
$18.3M
Nuevas posiciones
13
Posiciones cerradas
17
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 13 (-2 vs trimestre anterior) | 17 (-6 vs trimestre anterior) | 15 (-2 vs trimestre anterior) | 15 (-5 vs trimestre anterior) | -18.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Rubric Capital Management LP | $4 863 144 | 15 307 347 | 26,50% | Acciones |
| 683 Capital Management, LLC | $3 741 825 | 11 777 856 | 20,39% | Acciones |
| BANK OF AMERICA CORP /DE/ | $2 597 904 | 8 195 281 | 14,16% | Acciones |
| Defilade Capital Management, L.P. | $2 401 417 | 7 558 756 | 13,09% | Acciones |
| Newtyn Management, LLC | $953 100 | 3 000 000 | 5,19% | Acciones |
| Tejara Capital Ltd | $647 320 | 2 037 520 | 3,53% | Acciones |
| UBS Group AG | $460 346 | 1 447 627 | 2,51% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $419 123 | 1 319 241 | 2,28% | Acciones |
| EcoR1 Capital, LLC | $317 700 | 1 000 000 | 1,73% | Acciones |
| JANE STREET GROUP, LLC | $246 200 | 774 944 | 1,34% | Acciones |
| Ishara Investments LP | $244 232 | 768 750 | 1,33% | Acciones |
| Wealthspire Advisors, LLC | $243 041 | 765 000 | 1,32% | Acciones |
| CITADEL ADVISORS LLC | $160 407 | 504 900 | 0,87% | Opción de compra |
| CITADEL ADVISORS LLC | $141 109 | 444 158 | 0,77% | Acciones |
| TWO SIGMA ADVISERS, LP | $104 967 | 251 900 | 0,57% | Acciones |
| Rangeley Capital, LLC | $104 587 | 329 200 | 0,57% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $67 756 | 213 270 | 0,37% | Acciones |
| MARSHALL WACE, LLP | $57 563 | 179 884 | 0,31% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55 520 | 173 500 | 0,30% | Opción de compra |
| XTX Topco Ltd | $55 433 | 174 481 | 0,30% | Acciones |
| GROUP ONE TRADING LLC | $53 220 | 167 515 | 0,29% | Acciones |
| STATE STREET CORP | $42 817 | 134 772 | 0,23% | Acciones |
| Sheets Smith Investment Management | $34 793 | 16 890 | 0,19% | Acciones |
| NOMURA HOLDINGS INC | $33 155 | 104 361 | 0,18% | Acciones |
| James J. Burns & Company, LLC | $30 309 | 95 400 | 0,17% | Acciones |
| Quarry LP | $29 784 | 93 750 | 0,16% | Acciones |
| GOLDMAN SACHS GROUP INC | $27 062 | 85 180 | 0,15% | Acciones |
| JMN Financial LLC | $24 383 | 76 748 | 0,13% | Acciones |
| BlackRock, Inc. | $22 137 | 69 678 | 0,12% | Acciones |
| JPMORGAN CHASE & CO | $19 421 | 58 531 | 0,11% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $16 552 | 52 100 | 0,09% | Acciones |
| CITADEL ADVISORS LLC | $16 203 | 51 000 | 0,09% | Opción de venta |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14 720 | 46 000 | 0,08% | Opción de venta |
| Significant Wealth Partners LLC | $10 382 | 32 677 | 0,06% | Acciones |
| Clear Harbor Asset Management, LLC | $10 083 | 32 000 | 0,05% | Acciones |
| RHUMBLINE ADVISERS | $8 511 | 26 784 | 0,05% | Acciones |
| Centiva Capital, LP | $7 943 | 25 000 | 0,04% | Acciones |
| Engineers Gate Manager LP | $7 610 | 23 953 | 0,04% | Acciones |
| SIMPLEX TRADING, LLC | $5 972 | 18 780 | 0,03% | Acciones |
| NFSG Corp | $5 957 | 18 750 | 0,03% | Acciones |
| OneDigital Investment Advisors LLC | $5 814 | 18 300 | 0,03% | Acciones |
| MORGAN STANLEY | $5 317 | 16 731 | 0,03% | Acciones |
| IHT Wealth Management, LLC | $4 766 | 15 000 | 0,03% | Acciones |
| TWO SIGMA SECURITIES, LLC | $4 098 | 12 900 | 0,02% | Acciones |
| J. Safra Sarasin Holding AG | $4 081 | 12 841 | 0,02% | Acciones |
| MML INVESTORS SERVICES, LLC | $3 876 | 12 200 | 0,02% | Acciones |
| JANE STREET GROUP, LLC | $3 749 | 11 800 | 0,02% | Opción de compra |
| World Investment Advisors | $3 300 | 10 000 | 0,02% | Acciones |
| Astoria Portfolio Advisors LLC. | $3 177 | 10 000 | 0,02% | Acciones |
| GAMMA Investing LLC | $2 957 | 9 308 | 0,02% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×16 presentaciones | 17 de junio de 2024 | · | Presentación inicial | · | SEC |
| Mereo BioPharma Group plc, Dr. Denise Scots-Knight | 17 de diciembre de 2018 | · | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 13 insiders · 5 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Denise Scots-Knight | Chief Executive Officer | 1 de febrero de 2026 A | 808 921 | 0 | 0 | $0 |
| Chrisitne Ann Fox | Chief Financial Officer | 1 de febrero de 2026 A | 89 285 | 0 | 0 | $0 |
| Alexandra Hughes-Wilson | Chief Patient Access and Commercial Planning | 1 de febrero de 2026 A | 50 475 | 0 | 0 | $0 |
| Charles Sermon | General Counsel | 1 de febrero de 2026 A | 219 061 | 0 | 0 | $0 |
| John A. Lewicki | Chief Scientific Officer | 1 de febrero de 2026 A | 78 630 | 0 | 0 | $0 |
| Anders Ekblom | Consejero | 26 de febrero de 2026 A | · | 0 | 0 | $0 |
| Daniel Shames | Consejero | 26 de febrero de 2026 A | · | 0 | 0 | $0 |
| Jeremy Bender | Consejero | 26 de febrero de 2026 A | 12 550 | 0 | 0 | $0 |
| Pierre Jacquet | Consejero | 26 de febrero de 2026 A | · | 0 | 0 | $0 |
| Annalisa Jenkins | Consejero | 26 de febrero de 2026 A | · | 0 | 0 | $0 |
| Marc J Yoskowitz | Consejero | 26 de febrero de 2026 A | · | 0 | 0 | $0 |
| Deepika Pakianathan | Consejero | 26 de febrero de 2026 A | 0 | 0 | 0 | $0 |
| Michael S Wyzga | Consejero | 26 de febrero de 2026 A | 25 050 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
MREO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$1.93
+409,0%
5 35,7%
Compra fuerte
5 35,7%
Compra
3 21,4%
Mantener
1 7,1%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
5 analistas · 2026-10-01Objetivo medio $1.95 +414,5%
← Por Debajo de Todos los Objetivos
Precio Actual $0.38
Mín$0.98
Media$1.95
Máx$2.96
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 11, 2026